ANNA Richardson has just shared that despite vowing to never use fat jabs, she’s lost an incredible stone and a half thanks ...
Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.
The Economist has launched The World Ahead, the annual special year-end issue from The Economist that examines ...
The prolonged shutdown has taken a toll on consumer confidence and the overall economy, with consumer sentiment dropping to ...
Markets have turned upbeat amid optimism that the 39-day US shutdown could soon come to an end, after a weekend of dealmaking ...
Medicare coverage will cut obesity-drug prices but open the door to millions of new patients.
Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...
Statista on MSN
Ozempic Now a Major Player on the Diabetes Drug Market
According to the United Nations, the number of people with diabetes has almost quadrupled since 1980, and the prevalence of ...
El Mundo on MSN
The revolution of the 'Ozempic' drugs and the challenges of a solution for almost everything: "We are facing massive use"
A review by researchers from the Cochrane publication focuses on the new 'superdrugs': questioning the rebound effect, ...
Pfizer Inc. acquires Metsera, Inc., beating Novo Nordisk, for up to $86.25/share. Click for my analysis of the deal and what ...
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback